Our reputation is built on the trust and confidence of all our stakeholders and is one of AstraZeneca's most valuable assets.

Our business activities touch many people's lives, including patients, physicians, employees, investors and the communities around us. We know that how we do business, as well as what we do, is important to our reputation among these groups and wider society. Maintaining their trust and confidence in AstraZeneca as a responsible company means making sure that our high-level values and principles are translated into consistent and appropriate behaviour worldwide.

This section of our website describes our approach to managing the challenges and opportunities associated with our corporate responsibility to ensure that, alongside our commitment to competitiveness and top-tier performance, we continue to be led by our core values to achieve sustainable success.

In 2007, we conducted a project to review the possibility of applying the Global Reporting Initiative (GRI) guidelines to our reporting. GRI provides guidance for organisations to use as the basis for sustainability performance reporting, which gives stakeholders a consistent, comparable framework in which to understand disclosed information.   A cross-functional team including Human Resources, Compliance, Global Safety, Health and Environment and Corporate Communications, as well as Global CR, reviewed the GRI indicators against a number of criteria, such as their relevance to our CR approach and to the key target audiences for our reporting. The review also served as a means of identifying any gaps in our existing Priority Action Plan. The outcomes formed the basis of our decision to become a GRI B+ reporter. You can use the GRI Content Index to find the relevant GRI-related information within this website.